MSC Immune Tolerance in Cellular Cardiomyoplasty

Seminars in Thoracic and Cardiovascular Surgery

Volumn 20, Issue 2, 2008, Pages 115-118

  Chiu, Ray Chu Jeng ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

allogeneic; cellular cardiomyoplasty; immune tolerance; mechanisms; MSC; xenogeneic

Indexed keywords

HLA ANTIGEN; INTERLEUKIN 10;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIOMYOPLASTY; CELL BASED GENE THERAPY; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CLINICAL OBSERVATION; CLINICAL TRIAL; EXPERIMENTAL STUDY; FEASIBILITY STUDY; HEART INFARCTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; XENOTRANSPLANTATION;

ANIMALS; CARDIOMYOPLASTY; CELL DIFFERENTIATION; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 49049104412     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2008.03.004     Document Type: Article

References (20)

1. Toma C., Pittenger M.F., Cahill K.S., et al. Human mesenchymal stem cells differentiae to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
2. Liechty K.W., MacKenzie T.C., Shaaban A., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature Med 6 (2000) 1282-1286
3. Saito T., Kuang J.-Q., Bittira B., et al. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 74 (2002) 19-24
4. MacDonald D.J., Saito T., Shum-Tim D., et al. Persistence of marrow stromal cells implanted into acutely infracted myocardium: observations in a xenotransplant model. J Thorac Cardiovasc Surg 130 (2005) 1114-1121
5. Atoui R., Asenjo J.-F., Duong M., et al. Marrow stromal cells as "universal donor cells" for myocardial regenerative therapy: their unique immune tolerance. Ann Thorac Surg 85 (2008) 571-580
6. Dai W., Hale S., Martin B., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112 (2005) 214-223
7. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. PNAS 102 (2005) 11474-11479
8. Zambrano J., Traverse J.H., Henry T., et al. The impact of intravenous allogeneic human mesenchymal stem cells (Provacel™) on ejection fraction in patients with myocardial infarction. Circulation 116 (2007) II-202
9. Nauta A.J., and Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110 (2007) 3499-3506
10. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815-1822
11. Wang J.S., Shum-Tim D., Galipeau J., et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and clinical advantages. J Thorac Cardiovasc Surg 120 (2000) 999-1006
12. Le Blanc K., Tammik C., Rosendahl K., et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exper Hematol 31 (2003) 890-896
13. Liu C.T., Yang Y.J., Yin F., et al. The immunobiological development of human bone marrow mesenchymal stem cells in the course of neuronal differentiation. Cellular Immunol 244 (2006) 19-32
14. Chiu R. "Stealth immune tolerance" in stem cell transplantation: potential for "universal donors" in myocardial regenerative therapy. J Heart Lung Transplant 24 (2005) 511-516
15. Matzinger P. The danger model: a renewed sense of self. Science 296 (2002) 301-305
16. Poncelet A., Vercruysse J., Saliez A., et al. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 83 (2007) 783-790
17. Grinnemo K.H., Mansson A., Dellgren G., et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infracted rat myocardium. J Thorac Cardiovasc Surg 127 (2004) 1293-1300
18. Grinnemo K.H., Mansson-Broberg A., Le Blanc K., et al. Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med 38 (2006) 144-153
19. Kofidis T., deBruin, Zwierzchoniewska M., et al. They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-based lymphocyte host immune response. Eur J Cardiothorac Surg 28 (2005) 461-466
20. Bianchi D.W., Zickwolf G.K., Weil G.J., et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 93 (1996) 705-708